| Literature DB >> 19252527 |
W Al-Ahmadi1, L Al-Haj, F A Al-Mohanna, R H Silverman, K S A Khabar.
Abstract
Ribonuclease L (RNase L) is an intracellular enzyme that is vital in innate immunity, but also is a tumor suppressor candidate. Here, we show that overexpression of RNase L decreases cellular growth and downmodulates the RNA-binding protein, HuR, a regulator of cell-cycle progression and tumorigenesis. The effect is temporal, occurring in specific cell-cycle phases and correlated with the cytoplasmic localization of RNase L. Both cellular growth and HuR were increased in RNASEL-null mouse fibroblast lines when compared to wild-type cells. Moreover, the stability of HuR mRNA was enhanced in RNASEL-null cells. The HuR 3' untranslated region (UTR), which harbors U-rich and adenylate-uridylate-rich elements, was potently responsive to RNase L when compared to control 3' UTR. Our results may offer a new explanation to the tumor suppressor function of RNase L.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19252527 PMCID: PMC3071643 DOI: 10.1038/onc.2009.16
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867